Bioline Rx reported $13.62M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Arca Biopharma USD 16.63M 1.26M Mar/2026
Bio Path USD 9.15M 468K Mar/2026
Bioline Rx USD 13.62M 1.5M Mar/2026
Capricor Therapeutics USD 33.64M 2.2M Mar/2026